+Uncategorized | 861 days ago

Health Care: Is Obama Taking on the Biotech Industry?

By Karen Tumulty

A while back, Michael Scherer and I wrote this story about how the biotech industry has been one of the big winners in the health care debate.

Maybe not so much, it now appears. The New York Times reports that President Obama may be making a last stand to bring lower-cost generic biologics to market more quickly:

+Health Care | 946 days ago

Health Reform: How The Drug Companies Won A Big One

By Karen Tumulty

$609,000 a day. That’s how much the drug and biotech companies have been spending to influence Congress in the health reform debate, more than any other industry. So it’s no surprise that they have been extraordinarily successful. In the upcoming issue of dead-tree TIME, Michael Scherer and I look behind the scenes at the fight [...]